View Cart  

Merck, Roche Aim to Capture Hep C Market Via Collaboration

A A
To secure a greater market share for its recently approved hepatitis C (HCV) treatment Victrelis, Merck will collaborate with Roche to promote both companies’ HCV drugs for the disease.

To View This Article:

Login

Subscribe To Drug Industry Daily